OncoMed to Present Data From Three Clinical Studies at the 2014 ASCO Annual Meeting

REDWOOD CITY, Calif., May 14, 2014 -- OncoMed Pharmaceuticals Inc. , a clinical-stage company developing novel therapeutics that target cancer stem cells , or tumor-initiating cells, today highlighted data from several clinical studies that will be presented at the upcoming American Society for Clinical Oncology Annual Meeting being held May 30 - ... (more)

http://ift.tt/1mslBwx